Clinical Trial Update: Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) clinical trial evaluating the safety and efficacy of IR-101 for relapsed/refractory neuroblastoma is currently recruiting in Sichuan Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• IR-101

Snippet

Sponsor: Sichuan University | Conditions: Neuroblastoma | EARLY_Phase 1 | Status: RECRUITING